{"product_id":"assisted-reproduction-techniques-9781119622109","title":"Assisted Reproduction Techniques","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eAssisted reproduction techniques have led to the birth of 8 million babies worldwide\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eAssisted reproduction techniques (ART), in particular in-vitro fertilization and intra-cytoplasmic sperm injection, are the most advanced forms of infertility treatment. They involve numerous counseling, medical, surgical and laboratory-based steps. At each step various problems and complications could be encountered that challenge even the most experienced ART practitioners. Moreover, patients with complex medical disorders may require ART, presenting further challenges.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eAssisted Reproduction Techniques\u003c\/i\u003e will stimulate resourceful thinking in the ART practitioner when faced with these challenges. It outlines various management options, the reasoning behind them, and the evidence on which they are based to enable the practitioner to choose the most suitable solution for the needs of each patient.\u003c\/p\u003e \u003cp\u003eWritten by 171 internationally renowned experts, \u003ci\u003eAssisted Reproduct\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003eContributors xiii\u003c\/p\u003e \u003cp\u003ePreface to the second edition xxviii\u003c\/p\u003e \u003cp\u003ePreface to the first edition xxix\u003c\/p\u003e \u003cp\u003eHow to use this book xxx\u003c\/p\u003e \u003cp\u003eAbbreviations xxxi\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 1: Counseling and preparation \u003c\/b\u003e\u003cb\u003e1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Risk of cancer from ovarian stimulation 3\u003cbr\u003e\u003ci\u003eYadava Jeve\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Risk of early menopause following IVF treatment 9\u003cbr\u003e\u003ci\u003eSesh Kamal Sunkara\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 The HIV-positive female 12\u003cbr\u003e\u003ci\u003eMark V. Sauer and Shelley Dolitsky\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 The HIV-positive male 19\u003cbr\u003e\u003ci\u003eMark V. Sauer and Shelley Dolitsky\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 The hepatitis B or C carrier patient 26\u003cbr\u003e\u003ci\u003eJustin Chu\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 The patient with cystic fibrosis 32\u003cbr\u003e\u003ci\u003eTarek El‐Toukhy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 The patient on medication 37\u003cbr\u003e\u003ci\u003ePedro Melo and Arri Coomarasamy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 The patient with thrombophilia 48\u003cbr\u003e\u003ci\u003eYorain Sri Ranjan and Ying C. Cheong\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 The patient with autoimmune disorders 56\u003cbr\u003e\u003ci\u003eGiulia Mariani and José Bellver\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 The patient with malignant disease: fertility preservation 61\u003cbr\u003e\u003ci\u003eArri Coomarasamy and Manal Elgendy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 The patient with heart disease 69\u003cbr\u003e\u003ci\u003eAnna S. Herrey and Catherine Nelson-Piercy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 The patient with diabetes 75\u003cbr\u003e\u003ci\u003eMohammed A. Khan, Neelam Potdar, and Justin C. Konje\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 The patient with thyroid disease 81\u003cbr\u003e\u003ci\u003eShiao-yng Chan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 The patient with hyperprolactinemia 89\u003cbr\u003e\u003ci\u003eJohn Ayuk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 The patient with polycystic ovaries 96\u003cbr\u003e\u003ci\u003eAdam H. Balen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 The renal transplant patient 103\u003cbr\u003e\u003ci\u003eJustin Chu and Lynne Robinson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 The patient with previous pelvic irradiation 110\u003cbr\u003e\u003ci\u003eVishvanath C. Karande\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Female fertility after chemotherapy 116\u003cbr\u003e\u003ci\u003eNivedita Reddy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 The patient with abnormal cervical cytology 123\u003cbr\u003e\u003ci\u003eMartyn Underwood and William Rhys Parry-Smith\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 The patient with previous borderline ovarian tumor 127\u003cbr\u003e\u003ci\u003eArri Coomarasamy, Kavita Singh, and Jennifer Tamblyn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 The patient with an endometrioma 132\u003cbr\u003e\u003ci\u003eSpyros Chouliaras and Luciano G. Nardo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 The patient with cervical stenosis 137\u003cbr\u003e\u003ci\u003eKhaldoun Sharif\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Vaccination and ART 142\u003cbr\u003e\u003ci\u003eArri Coomarasamy and Rima Dhillon-Smith\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 The patient with hydrosalpinx 147\u003cbr\u003e\u003ci\u003eAnnika Strandell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 The patient with hydrosalpinx and contraindication to laparoscopy 153\u003cbr\u003e\u003ci\u003eBasim Abu-Rafea\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 The patient with reduced ovarian reserve 159\u003cbr\u003e\u003ci\u003eScott M. Nelson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 The patient with congenital uterine anomalies 166\u003cbr\u003e\u003ci\u003eRima Dhillon-Smith and Pallavi Latthe\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 The patient with congenital cervico-vaginal anomalies 171\u003cbr\u003e\u003ci\u003eRima Dhillon-Smith and Pallavi Latthe\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 The patient with uterine fibroids 176\u003cbr\u003e\u003ci\u003eKugajeevan Vigneswaran and Haitham Hamoda\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 The patient with adenomyosis 182\u003cbr\u003e\u003ci\u003eAndreas Athanasakis and Arri Coomarasamy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31 The patient with previous Essure® sterilization 187\u003cbr\u003e\u003ci\u003eT. Justin Clark\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 The patient with previous endometrial ablation 192\u003cbr\u003e\u003ci\u003eT. Justin Clark\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 The couple with recurrent implantation failure 200\u003cbr\u003e\u003ci\u003eLukasz Polanski and Yakoub Khalaf\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 The patient with previous uterine artery embolization 207\u003cbr\u003e\u003ci\u003eKugajeevan Vigneswaran and Haitham Hamoda\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 The patient with endometrial polyp 212\u003cbr\u003e\u003ci\u003eArri Coomarasamy and Laurentiu Craciunas\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 The obese female patient 217\u003cbr\u003e\u003ci\u003eMostafa Metwally and Bolarinde Ola\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 The patient with Asherman syndrome 223\u003cbr\u003e\u003ci\u003eAlessandro Conforti, Giuseppe Iorio, and Carlo Alviggi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38 The older patient 228\u003cbr\u003e\u003ci\u003eGiselle Crawford and William Ledger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e39 Requests for mild or natural cycle IVF treatment 234\u003cbr\u003e\u003ci\u003eBrad B. Swelstad and Suheil J. Muasher\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40 The patient with psychosexual problems 239\u003cbr\u003e\u003ci\u003ePenny Goold and Elizabeth Howland\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41 The patient needing third-party reproduction 246\u003cbr\u003e\u003ci\u003eImad Aboujaoude and Teddy Tadros\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42 Social oocyte freezing 252\u003cbr\u003e\u003ci\u003eValerie L. Peddie and Smriti Ray Chaudhuri Bhatta\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e43 The male and female patients following bariatric surgery 258\u003cbr\u003e\u003ci\u003eZaher Merhi and Ali Ahmed Bazzi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e44 Endometrial receptivity testing 265\u003cbr\u003e\u003ci\u003eLaurentiu Craciunas and Arri Coomarasamy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2: Pituitary suppression and ovarian stimulation phase \u003c\/b\u003e\u003cb\u003e271\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e45 Poor response during ovarian stimulation 273\u003cbr\u003e\u003ci\u003ePedro Melo, Lynne Robinson, and Arri Coomarasamy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e46 Ovarian stimulation for IVF in a patient at high risk of ovarian hyperstimulation syndrome 279\u003cbr\u003e\u003ci\u003eKhaldoun Sharif and Ahmed G. Serour\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e47 Unable to achieve pituitary down-regulation 284\u003cbr\u003e\u003ci\u003eK. Jayaprakasan and Nicholas Raine-Fenning\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e48 The patient discovered pregnant during pituitary down-regulation 291\u003cbr\u003e\u003ci\u003eMohammed Khairy Mahmoud and Arri Coomarasamy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e49 Ovarian cysts following pituitary down-regulation 296\u003cbr\u003e\u003ci\u003eAlison Taylor\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e50 Missed IVF medications 302\u003cbr\u003e\u003ci\u003ePedro Melo, Lynne Robinson, and Arri Coomarasamy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e51 The ART patient with a history of estrogen-receptor\u003cbr\u003epositive cancer 309\u003c\/p\u003e \u003cp\u003e\u003ci\u003eMurat Sönmezer and Volkan Turan\u003cbr\u003e\u003c\/i\u003e52 The patient over-responding to controlled ovarian stimulation during IVF 315\u003cbr\u003e\u003ci\u003eKhaldoun Sharif\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 3: Oocyte retrieval \u003c\/b\u003e\u003cb\u003e323\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e53 General anesthesia or sedation for oocyte retrieval? 325\u003cbr\u003e\u003ci\u003eClaire Scanlon and David Green\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e54 Delayed oocyte retrieval 331\u003cbr\u003e\u003ci\u003eKhaldoun Sharif\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e55 Empty follicle syndrome 337\u003cbr\u003e\u003ci\u003eAboubakr Mohamed Elnashar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e56 Bleeding following oocyte retrieval 344\u003cbr\u003e\u003ci\u003eAnnika K. Ludwig and Barbara Sonntag\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e57 To flush or not to flush follicles at oocyte retrieval 351\u003cbr\u003e\u003ci\u003eAnne E. Martini and Micah J. Hill\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e58 Inaccessible ovaries at oocyte retrieval 358\u003cbr\u003e\u003ci\u003eAboubakr Mohamed Elnashar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e59 Endometriotic cysts at oocyte retrieval 363\u003cbr\u003e\u003ci\u003eGraciela Kohls Ilgner and Juan Antonio García-Velasco\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e60 Inadvertent injury during oocyte retrieval 369\u003cbr\u003e\u003ci\u003eKhaldoun Sharif\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e61 Dealing with equipment failure during oocyte retrieval 377\u003cbr\u003e\u003ci\u003eIsla Robertson and Ying C. Cheong\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 4: Embryo transfer \u003c\/b\u003e\u003cb\u003e381\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e62 How many embryos to transfer? 383\u003cbr\u003e\u003ci\u003eEllen Armstrong and Arri Coomarasamy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e63 Poor endometrial development in ART 390\u003cbr\u003e\u003ci\u003eJyotsna Pundir and Arri Coomarasamy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e64 Endometrial cavity fluid identified during IVF treatment 400\u003cbr\u003e\u003ci\u003eArri Coomarasamy and Yealin Chung\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e65 Difficult embryo transfer 404\u003cbr\u003e\u003ci\u003eKhaldoun Sharif\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e66 Excess cervical mucus and retained embryos at embryo transfer 413\u003cbr\u003e\u003ci\u003eHassan N. Sallam, Ahmed F. Galal, and Fady S. Moeity\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e67 Life after embryo transfer 419\u003cbr\u003e\u003ci\u003eKelton Tremellen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 5: The luteal phase \u003c\/b\u003e\u003cb\u003e427\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e68 Vaginal bleeding in the luteal phase after IVF 429\u003cbr\u003e\u003ci\u003eCarol Coughlan and Bolarinde Ola\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e69 Pelvic infection after IVF 435\u003cbr\u003e\u003ci\u003eMuhammad Faisal Aslam and Ali Ahmad Bazzi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e70 The patient presenting with ovarian hyperstimulation syndrome 440\u003cbr\u003e\u003ci\u003eKhaldoun Sharif and Dania Al‐Ramahi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e71 Adnexal torsion after IVF 447\u003cbr\u003e\u003ci\u003eJenna Turocy and Beth W. Rackow\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e72 Exposure to infection in the luteal phase of IVF 453\u003cbr\u003e\u003ci\u003ePedro Melo and Arri Coomarasamy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 6: The ART laboratory \u003c\/b\u003e\u003cb\u003e465\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e73 Total failure of fertilization after conventional IVF – rescue ICSI 467\u003cbr\u003e\u003ci\u003eA. Albert Yuzpe\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e74 Couples not wishing to create surplus embryos in IVF 473\u003cbr\u003e\u003ci\u003eHossam Mohamed\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e75 Routine preimplantation genetic testing for aneuploidy 478\u003cbr\u003e\u003ci\u003eLukasz Polanski and Yakoub Khalaf\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e76 Choosing an embryo for transfer 484\u003cbr\u003e\u003ci\u003ePeter Kovacs and Szabolcs Matyas\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e77 Globozoospermia 492\u003cbr\u003e\u003ci\u003eOdai A. M. Alqawasmeh and Christopher L. R. Barratt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e78 Total failure of fertilization after ICSI 498\u003cbr\u003e\u003ci\u003eKaoru Yanagida\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e79 Refreezing of embryos 503\u003cbr\u003e\u003ci\u003eJerome H. Check and Donna Summers\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e80 Infection in embryo culture medium 509\u003cbr\u003e\u003ci\u003eAlison Campbell and Louise Best\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e81 ICSI or IVF for nonmale-factor infertility? 515\u003cbr\u003e\u003ci\u003eSamuel Dobson and Bolarinde Ola\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e82 Cryostorage failure in ART 522\u003cbr\u003e\u003ci\u003eChristopher P. Moutos, Angela H. Liu, and John Y. Phelps\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e83 The ART program during a disaster 527\u003cbr\u003e\u003ci\u003eRichard P. Dickey and Carla Ball White\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e84 Using the wrong sperm or embryos in IVF 533\u003cbr\u003e\u003ci\u003eKhaldoun Sharif and Majd M. Ezal‐Deen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 7: The male patient \u003c\/b\u003e\u003cb\u003e539\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e85 Unexpected inability to produce a semen sample on the day of oocyte retrieval 541\u003cbr\u003e\u003ci\u003eKhaldoun Sharif, Majd M. Ezal‐Deen, and Gyath Karadsheh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e86 The azoospermic patient 545\u003cbr\u003e\u003ci\u003eKhaldoun Sharif and Ali Al-Rawahneh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e87 ART in men with Klinefelter syndrome 553\u003cbr\u003e\u003ci\u003eMedhat Amer and Emad Fakhry\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e88 ART in men with 100% immotile sperm 559\u003cbr\u003e\u003ci\u003eJose Vázquez Núñez, Juan José Artazkoz Marques de Oliveira, Patricia Hernández Delgado, Ayrton Artazkoz Marques de Oliveira, and Neuda Marques de Oliveira\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e89 Request for posthumous fatherhood with perimortem surgical sperm retrieval 565\u003cbr\u003e\u003ci\u003eMahmoud Mima, Samuel J. Ohlander, Rodrigo L. Pagani, Heather E. Ross, and Lawrence S. Ross\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e90 Retrograde ejaculation and anejaculation 575\u003cbr\u003e\u003ci\u003eHussain M. Alnajjar and Asif Muneer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e91 Sperm retrieval in cancerous testes 580\u003cbr\u003e\u003ci\u003eWael Almajed, Saad Aldousari, and Armand Zini\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e92 Leukocytospermia and ART 584\u003cbr\u003e\u003ci\u003eGiuseppe Ricci\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e93 The infertile male patient with a genetic cause 589\u003cbr\u003e\u003ci\u003eMarlon P. Martinez and Ashok Agarwal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e94 Y chromosome microdeletions and ART 598\u003cbr\u003e\u003ci\u003eSherman J. Silber and Sierra Goldsmith\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e95 DNA fragmentation, antioxidants and ART 606\u003cbr\u003e\u003ci\u003eSarah J. Martins da Silva\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8: The ART pregnancy \u003c\/b\u003e\u003cb\u003e613\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e96 Unexpected number or sex of babies after IVF 615\u003cbr\u003e\u003ci\u003eMajd M. Ezal-Deen, Mohamad Bani-Domi, and Omar Sharif\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e97 Suspected ectopic pregnancy after IVF 620\u003cbr\u003e\u003ci\u003eVishvanath C. Karande, Liselotte Mettler,, and Ibrahim Alkatout\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e98 Cervical ectopic pregnancy after IVF 626\u003cbr\u003e\u003ci\u003eUsha Verma and Sabrina Pastor-Carvajal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e99 Heterotopic pregnancy after IVF 632\u003cbr\u003e\u003ci\u003eAbdel‐Maguid Ramzy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e100 Multifetal pregnancy reduction after IVF 638\u003cbr\u003e\u003ci\u003eOmar Taso and Maher Maaita\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e101 Multiple pregnancy after IVF: how to reduce preterm delivery 644\u003cbr\u003e\u003ci\u003eShawqi Saleh and Maysa Khadra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e102 Hyperreactio luteinalis after IVF 650\u003cbr\u003e\u003ci\u003eMuataz Al-Ramahi and Omar Sharif\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e103 Lactation by a commissioning mother in surrogacy 654\u003cbr\u003e\u003ci\u003ePavithra Rao and Frank P. Biervliet\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e104 Children of ART 658\u003cbr\u003e\u003ci\u003eDefne Saatci and Alastair G. Sutcliffe\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 9: General and organizational issues \u003c\/b\u003e\u003cb\u003e665\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e105 Managing physical symptoms during IVF 667\u003cbr\u003e\u003ci\u003eChiara Achilli and Jyotsna Pundir\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e106 IVF when the prognosis is very poor or futile 673\u003cbr\u003e\u003ci\u003eKhaldoun Sharif\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e107 Dealing with the emotional distress following failed IVF 678\u003cbr\u003e\u003ci\u003eSarah R. Holley, Lauri A. Pasch, and Alice D. Domar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e108 Couple splitting while embryos are in storage 684\u003cbr\u003e\u003ci\u003eMasoud Afnan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e109 Unexpected drop in the IVF clinic pregnancy rate 690\u003cbr\u003e\u003ci\u003eBulent Urman and Kayhan Yakin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e110 Natural fertility after IVF 696\u003cbr\u003e\u003ci\u003eFrank Nawroth and Annika K. Ludwig\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e111 Training in ART 699\u003cbr\u003e\u003ci\u003eRyan J. Heitmann\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e112 Keeping up to date in ART practice 706\u003cbr\u003e\u003ci\u003eBassel H. Al-Wattar and Khalid S. Khan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e113 Cross-border reproductive care 714\u003cbr\u003e\u003ci\u003eMahmoud Salama, Lynn M. Westphal, Marcia C. Inhorn, and Pasquale Patrizio\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e114 Satellite and transport ART treatment 720\u003cbr\u003e\u003ci\u003eM. F. González Echeverría and J. A. Blaquier\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e115 Social media use in ART 725\u003cbr\u003e\u003ci\u003eNatalie M. Crawford, Roohi Jeelani, Lora K. Shahine, and Kenan Omurtag\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e116 Managing an ART unit as a profitable business 733\u003cbr\u003e\u003ci\u003eMichael H. Fakih, Ahmad Fakih, and Amanda Fakih\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 739\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49407101796695,"sku":"9781119622109","price":148.45,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119622109.jpg?v=1730498183","url":"https:\/\/bookcurl.com\/products\/assisted-reproduction-techniques-9781119622109","provider":"Book Curl","version":"1.0","type":"link"}